Clinical Trials Logo
  1. Home
  2. Immune Response
  3. NCT06041867

Agaricus Bisporus and Influenza Vaccination Response

Immune Response Clinical Trial

Official title:
Mushboost: Evaluating the Effect of Agaricus Bisporus Powder Intake on the Vaccination Response to an Influenza Vaccine

Clinical Trial Summary

There are numerous in vitro and animal studies that suggested that mushrooms beneficially influence the immune system. We have recently shown that a wild isolate of the edible Agaricus bisporus mushroom had a clear effect on parameters reflecting a better function of the immune system, both in vitro and in vivo in animals. The question now is whether this efficacy can also be translated to humans. In humans, measuring the antibody response is the golden standard to evaluate immune function. If Agaricus bisporus powder indeed has beneficial effects on the immune system, people with overweight or obesity and higher age might benefit from consuming Agaricus bisporus powder prior to receiving the influenza vaccination.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06041867
Study type Interventional
Source Maastricht University Medical Center
Contact
Status Recruiting
Phase N/A
Start date September 14, 2023
Completion date May 30, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05515263 - Snack Foods and Their Impact on the Immune Response Following Influenza Vaccination N/A
Completed NCT02872311 - Open-Label Influenza Vaccine Evaluation N/A
Completed NCT01861613 - Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students Phase 4
Completed NCT03982069 - Immunologic Response to FluMist vs. Flucelvax Phase 4
Completed NCT03614975 - Immunologic Response to Influenza Vaccination in Children and Adolescents Phase 4
Completed NCT04573543 - The Role of Immune Semaphorins in NAFLD
Recruiting NCT03875703 - Post-Vaccination Biological Collection
Completed NCT00902278 - Immune Responses Induced by Different Licensed Influenza Vaccines N/A
Completed NCT00346619 - Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults Phase 1
Recruiting NCT04274348 - Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum N/A
Active, not recruiting NCT05534893 - Effect of Blueberries on Immunity and Response to Flu Vaccination N/A
Completed NCT05970887 - Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines Phase 4
Completed NCT05706350 - Plant Stanol Esters and Influenza Vaccination N/A
Completed NCT03167593 - Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65. Phase 2
Completed NCT04386408 - Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections Phase 1
Completed NCT02933931 - Immune Durability After VSV-EBOV Vaccination
Recruiting NCT01289535 - Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years Phase 4
Active, not recruiting NCT02441426 - Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development N/A
Recruiting NCT03399357 - Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial N/A
Active, not recruiting NCT05852964 - Inflammatory and Anti-Inflammatory Gene Expressions in Liver Transplant Patients